A gene signature derived from leukemia associated macrophages provides a compelling risk stratification for human AML patients
Deedra Nicolet(The Ohio State University), Tianxiang Hu(National Cancer Center of Georgia), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Christopher J. Walker(The Ohio State University), Justice Ameyi(The Ohio State University), Xuexiu Fang(National Cancer Center of Georgia), Ann-Kathrin Eisfeld(The Ohio State University), Jorge Cortes(National Cancer Center of Georgia), Ting Zhang(Tianjin University of Traditional Chinese Medicine), Catherine C. Hedrick(Augusta University), Stephanie F. Mori(National Cancer Center of Georgia), John K. Cowell(National Cancer Center of Georgia)
Cited by 0
Related Papers
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
|The Lancet Neurology|2010|1.4k
Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
|Journal of Clinical Oncology|2012|408
<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures
|Journal of Clinical Oncology|2012|268
Age-Related Prognostic Impact of Different Types of <i>DNMT3A</i> Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia
|Journal of Clinical Oncology|2012|255